These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7268622)

  • 1. The role of antibody in tumor immunity.
    Economou JS
    Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-linked cytotoxic agents in the treatment of cancer: current status and future prospects.
    Ghose T; Blair AH
    J Natl Cancer Inst; 1978 Sep; 61(3):657-76. PubMed ID: 80453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on antibodies against rat and mouse tumors: its application to therapy].
    Tsukada Y
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2069-76. PubMed ID: 6614940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bi-specific antibody therapy for the treatment of cancer.
    Withoff S; Helfrich W; de Leij LF; Molema G
    Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of tumor immunity: the role of antibody and nonimmune effectors.
    Shin HS; Johnson RJ; Pasternack GR; Economou JS
    Prog Allergy; 1978; 25():163-210. PubMed ID: 362428
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic spread and "escape" from the immune defenses of the host.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
    Kennedy RC; Shearer MH; Watts AM; Bright RK
    Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotherapy of malignant disease.
    Wright PW; Bernstein ID
    Prog Exp Tumor Res; 1980; 25():140-62. PubMed ID: 6986629
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity.
    Mihich E
    Natl Cancer Inst Monogr; 1971 Dec; 34():90-102. PubMed ID: 4400958
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor resistance to specific lysis: a major hurdle for successful immunotherapy of cancer.
    Chouaib S; Meslin F; Thiery J; Mami-Chouaib F
    Clin Immunol; 2009 Jan; 130(1):34-40. PubMed ID: 19013109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination for treatment of tumors: a critical comment.
    Sedlacek HH
    Crit Rev Oncog; 1994; 5(6):555-87. PubMed ID: 8519811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.